Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.

BACKGROUND: To elucidate whether repeated exposures to iodinated contrast media increase the risk of adverse reaction. MATERIALS AND METHODS: We retrospectively reviewed 1,861 patients with hepatocellular carcinoma who visited authors' institution, a tertiary referral center, between 2004 and 2...

Full description

Bibliographic Details
Main Authors: Naoto Fujiwara, Ryosuke Tateishi, Masaaki Akahane, Masataka Taguri, Tatsuya Minami, Shintaro Mikami, Masaya Sato, Koji Uchino, Kenichiro Enooku, Yuji Kondo, Yoshinari Asaoka, Noriyo Yamashiki, Tadashi Goto, Shuichiro Shiina, Haruhiko Yoshida, Kuni Ohtomo, Kazuhiko Koike
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3788769?pdf=render
id doaj-6a1025fef1344d6ca446e4eac3126a3f
record_format Article
spelling doaj-6a1025fef1344d6ca446e4eac3126a3f2020-11-25T01:34:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01810e7601810.1371/journal.pone.0076018Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.Naoto FujiwaraRyosuke TateishiMasaaki AkahaneMasataka TaguriTatsuya MinamiShintaro MikamiMasaya SatoKoji UchinoKenichiro EnookuYuji KondoYoshinari AsaokaNoriyo YamashikiTadashi GotoShuichiro ShiinaHaruhiko YoshidaKuni OhtomoKazuhiko KoikeBACKGROUND: To elucidate whether repeated exposures to iodinated contrast media increase the risk of adverse reaction. MATERIALS AND METHODS: We retrospectively reviewed 1,861 patients with hepatocellular carcinoma who visited authors' institution, a tertiary referral center, between 2004 and 2008. We analyzed cumulative probability of adverse reactions and risk factors. We categorized all symptoms into hypersensitivity reactions, physiologic reactions, and other reactions, according to the American College of Radiology guidelines, and evaluated each category as an event. We estimated the association between hazard for adverse reactions and the number of cumulative exposures to contrast media. We also evaluated subsequent contrast media injections and adverse reactions. RESULTS: There were 23,684 contrast media injections in 1,729 patients. One hundred and thirty-two patients were excluded because they were given no contrast media during the study period. Adverse reactions occurred in 196 (0.83%) patients. The cumulative incidence at 10(th), 20(th), and 30(th) examination was 7.9%, 15.2%, and 24.1%, respectively. Presence of renal impairment was found to be one of risk factors for adverse reactions. The estimated hazard of overall adverse reaction gradually decreased until around 10(th) exposure and rose with subsequent exposures. The estimated hazard of hypersensitivity showed V-shaped change with cumulative number of exposures. The estimated hazard of physiologic reaction had a tendency toward decreasing and that of other reaction had a tendency toward increasing. Second adverse reaction was more severe than the initial in only one among 130 patients receiving subsequent injections. CONCLUSION: Repeated exposures to iodinated contrast media increase the risk of adverse reaction.http://europepmc.org/articles/PMC3788769?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Naoto Fujiwara
Ryosuke Tateishi
Masaaki Akahane
Masataka Taguri
Tatsuya Minami
Shintaro Mikami
Masaya Sato
Koji Uchino
Kenichiro Enooku
Yuji Kondo
Yoshinari Asaoka
Noriyo Yamashiki
Tadashi Goto
Shuichiro Shiina
Haruhiko Yoshida
Kuni Ohtomo
Kazuhiko Koike
spellingShingle Naoto Fujiwara
Ryosuke Tateishi
Masaaki Akahane
Masataka Taguri
Tatsuya Minami
Shintaro Mikami
Masaya Sato
Koji Uchino
Kenichiro Enooku
Yuji Kondo
Yoshinari Asaoka
Noriyo Yamashiki
Tadashi Goto
Shuichiro Shiina
Haruhiko Yoshida
Kuni Ohtomo
Kazuhiko Koike
Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
PLoS ONE
author_facet Naoto Fujiwara
Ryosuke Tateishi
Masaaki Akahane
Masataka Taguri
Tatsuya Minami
Shintaro Mikami
Masaya Sato
Koji Uchino
Kenichiro Enooku
Yuji Kondo
Yoshinari Asaoka
Noriyo Yamashiki
Tadashi Goto
Shuichiro Shiina
Haruhiko Yoshida
Kuni Ohtomo
Kazuhiko Koike
author_sort Naoto Fujiwara
title Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
title_short Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
title_full Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
title_fullStr Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
title_full_unstemmed Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
title_sort changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: To elucidate whether repeated exposures to iodinated contrast media increase the risk of adverse reaction. MATERIALS AND METHODS: We retrospectively reviewed 1,861 patients with hepatocellular carcinoma who visited authors' institution, a tertiary referral center, between 2004 and 2008. We analyzed cumulative probability of adverse reactions and risk factors. We categorized all symptoms into hypersensitivity reactions, physiologic reactions, and other reactions, according to the American College of Radiology guidelines, and evaluated each category as an event. We estimated the association between hazard for adverse reactions and the number of cumulative exposures to contrast media. We also evaluated subsequent contrast media injections and adverse reactions. RESULTS: There were 23,684 contrast media injections in 1,729 patients. One hundred and thirty-two patients were excluded because they were given no contrast media during the study period. Adverse reactions occurred in 196 (0.83%) patients. The cumulative incidence at 10(th), 20(th), and 30(th) examination was 7.9%, 15.2%, and 24.1%, respectively. Presence of renal impairment was found to be one of risk factors for adverse reactions. The estimated hazard of overall adverse reaction gradually decreased until around 10(th) exposure and rose with subsequent exposures. The estimated hazard of hypersensitivity showed V-shaped change with cumulative number of exposures. The estimated hazard of physiologic reaction had a tendency toward decreasing and that of other reaction had a tendency toward increasing. Second adverse reaction was more severe than the initial in only one among 130 patients receiving subsequent injections. CONCLUSION: Repeated exposures to iodinated contrast media increase the risk of adverse reaction.
url http://europepmc.org/articles/PMC3788769?pdf=render
work_keys_str_mv AT naotofujiwara changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT ryosuketateishi changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT masaakiakahane changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT masatakataguri changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT tatsuyaminami changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT shintaromikami changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT masayasato changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT kojiuchino changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT kenichiroenooku changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT yujikondo changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT yoshinariasaoka changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT noriyoyamashiki changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT tadashigoto changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT shuichiroshiina changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT haruhikoyoshida changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT kuniohtomo changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
AT kazuhikokoike changesinriskofimmediateadversereactionstoiodinatedcontrastmediabyrepeatedadministrationsinpatientswithhepatocellularcarcinoma
_version_ 1725069735623655424